drug
as of 2026-07-01Ginkgo Biloba Extract
Ginkgo biloba extract
MeSH C063170
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Beijing HuiLongGuan Hospital
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
2
Ginkgo Biloba Extract in the Treatment of Schizophrenia
NCT05258123—Completed
Ginkgo Biloba Extract for Schizophrenia
NCT01524380—Completed
KOLs & investigators
2
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication
KOL
Xiang Y Zhang, M.D, Ph.D
personKOL score —
Xiang Y Zhang, MD/PhD
personKOL score —